Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 40
Summary
- Conditions
- Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia
- Biphenotypic/Undifferentiated Leukemia
- Burkitt Lymphoma
- Chronic Myelogenous Leukemia
- Hodgkin Lymphoma
- Lymphoplasmacytic Lymphoma
- Mantle Cell Lymphoma
- Myelodysplasia
- Relapsed Large Cell Lymphoma
- Relapsed T-Cell Lymphoma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 55 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03674411
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon